Tag: CISPD3

Sintilimab plus FOLFIRINOX may provide benefits in metastatic pancreatic cancer

Presented By
Dr Qihan Fu, Zhejiang University School of Medicine, China
Trial
Phase 3, CISPD3
Conference
ASCO GI 2022
Type
Peer-reviewed article

21 March 2022 12:43
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com